Navigation Links
Queen's scientists seek vaccine for Pseudomonas infection
Date:3/7/2012

Queen's University scientists working on a vaccine to combat Pseudomonas have received a major financial boost from Northern Ireland Chest Heart and Stroke (NICH&S).

The local charity has awarded Queen's Centre for Infection and Immunity a grant of 91,000 to help with their hunt for a vaccine.

Pseudomonas, which can be a killer in vulnerable adults and children, commonly infects the lungs of people suffering from cystic fibrosis (CF). CF damages a number of vital organs, particularly the lungs. It currently affects one in 2,500 newborn babies and Pseudomonas infection occurs in 80 per cent of adults living with CF. Currently in Northern Ireland CF affects 440 people in Northern Ireland, 190 of them children.

If a vaccine can be found, survival rates would increase for those affected by the serious genetic condition.

CF is caused by a genetic defect which results in thick, sticky mucous in the lungs, which becomes infected with bugs, in particular Pseudomonas. These bugs are almost impossible to eradicate, even with long-term antibiotics. This results in damage to the lungs, ultimately leading to early death through breathing difficulties.

Professor Stuart Elborn and Dr Rebecca Ingram, from Queen's Centre for Infection and Immunity are leading the study. Dr Ingram said: "Pseudomonas is around us all the time, and is normally cleared easily from our bodies, however, the mucus in the lungs of CF patients creates a perfect environment for the bacteria to live and multiply.

"In our study, patients' blood cells are placed on a special membrane and then mixed with different parts of the bacteria, to see if the body recognises them and so releases 'attack' molecules to deal with the infection. A dye is used to highlight the spots where this process is happening. It is the first time the technique has been used to examine human responses to Pseudomonas. Knowing which parts of the infection can most easily be recognised by the body will be a key piece in the jigsaw leading to the discovery of a vaccine."

The Chief Executive of NI Chest Heart & Stroke, Andrew Dougal, said: "Cystic fibrosis is a devastating illness primarily affecting the lungs. We are delighted to be supporting this high quality local research at Queen's, which brings hope of a Pseudomonas vaccine to improve survival rates. Often, these research grant awards are made possible only by the generosity of people who bequeath money to us in their wills. Legacies have become a vitally important source of income at a time of economic downturn".


'/>"/>

Contact: Lisa McElroy
lisa.mcelroy@qub.ac.uk
44-289-097-5384
Queen's University Belfast
Source:Eurekalert

Related biology news :

1. Protein love triangle key to crowning bees queens?
2. Clemson University and the University of Queensland form biofuels research partnership
3. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
4. A*STAR scientists make groundbreaking discovery on stem cell regulation
5. Scripps Florida scientists awarded $3 million to develop new, more effective pain treatments
6. Scientists learn how insects remodel their bodies between life stages
7. UF scientists name new ancient camels from Panama Canal excavation
8. MU scientists study how to improve pesticide efficiency
9. Southern insect scientists to meet in Little Rock
10. Emerge attracts futurists to collaborate with scientists, designers artists is redesign of future
11. Geological Society of America member scientists, students, and colleagues meet in Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology: